# Optimizing tDCS Protocol for Clinical Use in Major Depressive Disorder

> **NCT06165445** · NA · COMPLETED · sponsor: **The National Brain Mapping Laboratory (NBML)** · enrollment: 60 (actual)

## Conditions studied

- Depressive Disorder
- Cognitive Impairment
- Psychiatric Disorder

## Interventions

- **DEVICE:** transcranial direct current stimulation (tDCS)
- **DEVICE:** multichannel transcranial direct current stimulation (tDCS)

## Key facts

- **NCT ID:** NCT06165445
- **Lead sponsor:** The National Brain Mapping Laboratory (NBML)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-03-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06165445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06165445, "Optimizing tDCS Protocol for Clinical Use in Major Depressive Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06165445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*